2023 Annual Report - Growing Community

GROWING

2023 ANNUAL REPORT

TABLE OF CONTENTS

GROWING COMMUNITY THROUGH RESEARCH

GROWING COMMUNITY THROUGH SCIENTIFIC PROGRAMS

GROWING COMMUNITY THROUGH EVENTS

GROWING COMMUNITY THROUGH FUNDRAISING

GROWING COMMUNITY THROUGH SUPPORT SERVICES

FINANCIALS

GROWING COMMUNITY THROUGH OUR DONORS

As we reflect on 2023, we see a year in which the Foundation was able to make new connections, grow our community, and expand the impact of our mission and the reach of our work.

LETTER FROM THE CEO & CHAIR OF THE BOARD

Dear Friends,

Every year, we are humbled to highlight the growth and incredible progress made by the Lymphoma Research Foundation (LRF), which is made possible through your generosity and commitment to our mission to eradicate lymphoma and serve those touched by this disease.

As we reflect on 2023, we see a year in which the Foundation was able to make new connections, grow our community, and expand the impact of our mission and reach of our work. We were able to convene many of our in-person patient and professional programs for the first time in three years and expand our online offerings for patients as well. Being back in person for events like Partners In Hope allowed devoted partners like Liam Hendriks of the Chicago White Sox and his wife, Kristi, to join us and tell their story. Our Annual Gala raised over a million dollars for our mission and was globally supported by our devoted partners and industry leaders. New friends, like TikTok star Anthony Corrado, joined us for our Chicago Walk, encouraging others to join our journey and efforts. Our hybrid education programs ensured that thousands of patients and their families could access expert information and support in whichever way made them comfortable. We also continued to grow online and through services like the LRF Helpline, serving more than 10,000 patients and caregivers last year alone.

Chief Executive Officer

The Foundation continues to fund a robust portfolio of cutting-edge research across every lymphoma subtype, and in 2023, LRF funded 27 research grants totaling nearly $6 million. This year’s report details our many grantees and the critical projects that would not be possible without your continued generous support.

In partnership with our expert Scientific Advisory Board, the Foundation was also able to harness its convening power to address important areas of unmet need. In 2023, LRF explored two of these critical areas: Mantle Cell Lymphoma (MCL) and Minimum Residual Disease (MRD). LRF also officially ratified the charter of its global Adolescent and Young Adult (AYA) Lymphoma Consortium, a first-of-its-kind effort aimed at bridging the gap in care that is experienced by this underserved patient population, as we continue to lead the way in the investigation of those lymphomas that disproportionately impact young people. LRF also began a new effort focused on the unique and understudied needs of lymphoma and CLL survivors, meeting an unmet need that will grow in the years ahead.

While much work remains, your partnership and dedication propel us forward each and every day. We remain as dedicated as ever to our shared goals and service to the more than 1 million Americans living with and surviving lymphoma.

Growing together,

Steven Eichberg Chair, Board of Directors

Meghan Gutierrez Chief Executive Officer

Meghan Gutierrez

Steven Eichberg Chair, Board of Directors

FY

STEVEN EICHBERG

Chair Plymouth, MA

JEFF BLOCK

Vice Chair and Treasurer San Francisco, CA

KIM METCALF

Vice Chair Landenberg, PA

LEIGH OLSON

Secretary Miami Beach, FL

MICHAEL AKINYELE Upper Marlboro, MD

MICHAEL FROY Chicago, IL

HARRIET GREENBERG New York, NY

JOHN LEONARD, MD

Past Chair, Scientific Advisory Board New York, NY

BOB MCAULEY Charlottesville, VA

JOHN A. NELSON Bridgehampton, NY

SCOTT PANSKY Tarzana, CA

DIANE PARKS Carbondale, CO

JOEL POLLICK Brooklyn, NY

STEVEN J. PRINCE Past Chair Purchase, NY

KEVIN SHEA Naples, FL

SONALI M. SMITH, MD, FASCO Chair, Scientific Advisory Board Chicago, IL

MICHAEL WERNER Immediate Past Chair Chicago, IL

MEMBERS EMERITUS MORTON COLEMAN, MD New York, NY

BARBARA FREUNDLICH Founder New York, NY

TOM GOLDSTONE New York, NY

DONNA REINBOLT Houston, TX

ROBERT WERNER Aventura, FL

MARTHA

AMY KIMBALL Easton, MD

LEWIS KWEIT Long Island, NY

KATHRYN MCGILL Dallas, TX

JACKIE QUAN Washington, DC

ADWIN SPRINGER London, Ontario, Canada

LYNDSAY SPRINGER Washington, DC

GARY TURKISH Hilton Head,

GROWING COMMUNITY THROUGH OUR SCIENTIFIC ADVISORY BOARD

FY 2023 MEMBERSHIP

SONALI M. SMITH, MD, FASCO

Chair

The University of Chicago

ANN S. LACASCE, MD, MMSc Chair-Elect

Harvard Medical School Dana-Farber Cancer Institute

RANJANA ADVANI, MD Stanford University School of Medicine

ASH A. ALIZADEH, MD, PhD Stanford University School of Medicine

STEPHEN ANSELL, MD, PhD Mayo Clinic, Rochester

KRISTIE A. BLUM, MD

Winship Cancer Institute of Emory University

JENNIFER BROWN, MD Dana-Farber Cancer Institute

JAMES CERHAN, MD, PhD

Mayo Clinic, Rochester

ETHEL CESARMAN, MD, PhD

NewYork-Presbyterian Hospital

Weill Cornell Medicine

BRUCE D. CHESON, MD, FACP, FAAAS, FASCO

Past Chair, 2010-2012

The Center for Cancer and Blood Disorders

SANDEEP DAVE, MD, MS Duke University

KIERON M. DUNLEAVY, MD

Georgetown Lombardi Comprehensive Cancer Center

KOJO S.J. ELENITOBA-JOHNSON, MD

Memorial Sloan Kettering Cancer Center

ANDREW M. EVENS, DO, MSc, FACP

Rutgers Cancer Institute of New Jersey

CHRISTOPHER R. FLOWERS, MD, MS

The University of Texas MD Anderson Cancer Center

JONATHAN W. FRIEDBERG, MD, MMSc

University of Rochester

James P. Wilmot Cancer Institute

LEO I. GORDON, MD, FACP

Past Chair, 2015-2017

Robert H. Lurie Comprehensive Cancer Center of Northwestern University

MICHAEL GREEN, PhD

The University of Texas MD Anderson Cancer Center

THOMAS M. HABERMANN, MD

Past Chair, 2017-2019 Mayo Clinic, Rochester

STEVEN M. HORWITZ, MD

Memorial Sloan Kettering Cancer Center

ERIC D. HSI, MD Wake Forest

BRAD S. KAHL, MD

Washington University School of Medicine

KARA KELLY, MD

Roswell Park Comprehensive Cancer Center University at Buffalo Jacobs School of Medicine and Biomedical Sciences

JOHN P. LEONARD, MD

Past Chair, 2012-2015 NewYork-Presbyterian Hospital Weill Cornell Medicine

BRIAN K. LINK, MD University of Iowa

IZIDORE S. LOSSOS, MD

University of Miami Health System Sylvester Comprehensive Cancer Center

PETER MARTIN, MD

Weill Cornell Medicine

ARI MELNICK, MD

NewYork-Presbyterian Hospital Weill Cornell Medicine

LINDSAY MORTON, PhD National Cancer Institute

LORETTA NASTOUPIL, MD

The University of Texas MD Anderson Cancer Center

TERESA PALOMERO, PhD

Institute for Cancer Genetics, Columbia University

LAURA PASQUALUCCI, MD

Institute for Cancer Genetics, Columbia University

BARBARA PRO, MD Columbia University

H. Irving Comprehensive Cancer Center

LISA RIMSZA, MD Mayo Clinic, Arizona

LISA GIULINO ROTH, MD Weill Cornell Medicine

KERRY J. SAVAGE, MD BC Cancer, Vancouver

DAVID W. SCOTT, MBChB, PhD BC Cancer, Vancouver

LAURIE SEHN, MD, MPH BC Cancer, Vancouver

MARGARET SHIPP, MD

Harvard Medical School

Dana-Farber Cancer Institute

EDUARDO M. SOTOMAYOR, MD Tampa General Hospital

CHRISTIAN STEIDL, MD BC Cancer, Vancouver

JOHN M. TIMMERMAN, MD

UCLA Jonsson Comprehensive Cancer Center

SVEN de VOS, MD, PhD

UCLA Jonsson Comprehensive Cancer Center

HANS-GUIDO WENDEL, MD

Memorial Sloan Kettering Cancer Center

ANDREW D. ZELENETZ, MD, PhD

Immediate Past Chair, 2019-2021

Memorial Sloan Kettering Cancer Center

MEMBERS EMERITUS

MORTON COLEMAN, MD

NewYork-Presbyterian Hospital Weill Cornell Medicine

KANTI R. RAI, MD

Donald and Barbara Zucker School of Medicine at Hofstra/Northwell

MICHAEL E. WILLIAMS, MD, ScM

University of Virginia Cancer Center

GROWING COMMUNITY THROUGH RESEARCH

In April, the Lymphoma Research Foundation (LRF) announced its 2023 grant class — 27 research grants awarded to scientists based at many of the world’s leading cancer research institutions — totaling more than $5.4 million in innovative lymphoma and chronic lymphocytic leukemia (CLL) research.

LRF maintains a strong commitment to supporting early-career investigators, ensuring they can build a successful career in the field of lymphoma research. This commitment is illustrated by the 16 grants awarded to early-career investigators this year. They include four dynamic Clinical Investigator Career Development Awards (CDA), which support physician investigators at the level of advanced fellow or junior faculty member who will contribute to the development of new lymphoma therapies and diagnostic tools. Also included are seven Postdoctoral Fellowship Grants, designed to support investigators at the level of advanced fellow or postdoctoral researcher in laboratory or clinic-based research with results and conclusions that must be relevant to the treatment, diagnosis, or prevention of lymphoma.

CLINICAL CAREER DEVELOPMENT AWARD (CDA)

ELISE CHONG, MD

Health Equity Initiative & LRF’s 500th Grantee

UNIVERSITY OF PENNSYLVANIA, PERELMAN SCHOOL OF MEDICINE

RONI SHOUVAL, MD, PHD

MEMORIAL SLOAN KETTERING CANCER CENTER

PATRIZIA MONDELLO, MD, PHD

MAYO CLINIC, ROCHESTER

XIAOLONG (ALAN) ZHOU, MD

NORTHWESTERN UNIVERSITY FEINBERG SCHOOL OF MEDICINE

“My goal is to maintain a strong connection to patient care, bringing the latest advancements in research directly to those who stand to benefit from them.”

Roni Shouval, MD, PhD

FOLLICULAR LYMPHOMA PRIORITY RESEARCH GRANT

Also this year, LRF funded five Follicular Lymphoma Priority Research grants as part of the Jamie Peykoff Follicular Lymphoma Initiative. Established in 2020 through the generosity of the Peykoff family and The Institute for Follicular Lymphoma, the $10 million Initiative is poised to transform the follicular lymphoma (FL) treatment landscape for tens of thousands of patients by harnessing the Foundation’s unique resources, convening the world’s experts in FL research and patient care, and driving direct investment in clinical research.

ARASH ALIZADEH, MD, PHD

Peykoff Initiative Investigator STANFORD UNIVERSITY

WENDY BÉGUELIN, PHD

Peykoff Initiative Investigator

WEILL MEDICAL COLLEGE OF CORNELL UNIVERSITY

JOSHUA BRODY, MD

Peykoff Initiative Investigator

ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI

ROBERT KRIDEL, MD, MPH, PHD

Peykoff Initiative Investigator UNIVERSITY HEALTH NETWORK, TORONTO

MATTHEW MAURER, D.M.SC

Peykoff Initiative Investigator

MAYO CLINIC, ROCHESTER

POSTDOCTORAL FELLOWSHIP GRANT

EDWARD DOMINGUEZ, PHD

Health Equity Initiative BECKMAN RESEARCH INSTITUTE OF CITY OF HOPE

TAYLA HEAVICAN-FORAL, PHD

Health Equity Initiative & Dr. Oliver Press Memorial Fellow

DANA-FARBER CANCER INSTITUTE

ANOUCHKA LAURENT, PHD COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK

YIFEI LIAO, PHD BRIGHAM AND WOMEN’S HOSPITAL

CHRISTOPHER SAUTER, MD

PERELMAN SCHOOL OF MEDICINE, UNIVERSITY OF PENNSYLVANIA

SANKET SHAH, PHD

Dr. Bruce D. Cheson Fellow

WEILL MEDICAL COLLEGE OF CORNELL UNIVERSITY

AJLAN AL ZAKI, MD, PHD

THE UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER

“I was drawn to lymphoma research because it represents the forefront of translating scientific knowledge into actionable therapies for patients.”

Christopher Sauter, MD

LYMPHOMA SCIENTIFIC RESEARCH MENTORING PROGRAM:

CLINICAL SCHOLARS

AYUSHI CHAUHAN, MD

Gregory Scholar

AUGUSTA UNIVERSITY

DANIEL ERMANN, MD

UNIVERSITY OF UTAH

ERIKA HAYDU, MD, PHD

Runge Scholar

MASSACHUSETTS GENERAL HOSPITAL

SWETHA KAMBHAMPATI, MD

CITY OF HOPE

CHRISTINE RYAN, MD

Rai Scholar

DANA-FARBER CANCER INSTITUTE

TIMOTHY VOORHEES, MD

OHIO STATE UNIVERSITY

LYMPHOMA SCIENTIFIC RESEARCH MENTORING PROGRAM:

LAB/TRANSLATIONAL SCHOLARS

ALEXANDER BOARDMAN, MD

Dobosh Family Scholar

MEMORIAL SLOAN KETTERING

ANDREW JALLOUK, MD, PHD

MD ANDERSON CANCER CENTER

ERIN PARRY MD, PHD

DANA-FARBER CANCER INSTITUTE

AJLAN AL ZAKI, MD, PHD

MD ANDERSON CANCER CENTER

WEN-HSUAN WENDY LIN, MD, PHD

COLUMBIA UNIVERSITY

GROWING COMMUNITY THROUGH SCIENTIFIC PROGRAMS

Facilitating collaboration and partnerships among academic scientists, clinicians, government, regulatory agencies, and patients is a critical component of the Foundation’s work. Through its global lymphoma consortia, research initiatives, and scientific workshops, the Lymphoma Research Foundation (LRF) mobilizes the research community to overcome systemic challenges and expedite the development of treatments. In 2023, LRF used its convening power to explore two important areas of scientific discovery and unmet need: mantle cell lymphoma (MCL) and Minimum Residual Disease (MRD).

Mantle Cell Lymphoma (MCL)

Mantle cell lymphoma (MCL) is a rare, typically aggressive form of non-Hodgkin lymphoma (NHL) that accounts for roughly 6% of all NHL cases in the United States. Recognizing that a targeted research focus on MCL would benefit this underserved and understudied patient population, the Lymphoma Research Foundation (LRF) began awarding MCL-specific research grants and gathering its MCL grantees for a regular scientific meeting to report on their findings and form collaborations. Twenty years since the Workshop’s initial establishment, LRF hosted an MCL Scientific Workshop in May 2023 chaired by LRF Scientific Advisory Board Member Dr. Eduardo Sotomayor, MD (Tampa General Hospital Cancer Institute). The program also included a keynote speech from world-leading MCL expert Elias Campo, MD, PhD (Institut d’Investigacions Biomèdiques August Pi i Sunyer), who was honored with LRF’s Leadership Award for his contributions to the field of MCL research. Dr. Campo and Dr. Sotomayor shared more about this year’s meeting and what the future of MCL research holds.

Minimum Residual Disease (MRD)

Minimal residual disease (MRD) is the persistence or reemergence of detectable tumor cells after cancer treatment. A quantitative definition, however, remains elusive, as more effective therapies have increasingly reduced tumor burden, while increasingly sensitive MRD tests have enabled lower and lower thresholds of detection. It is now widely agreed that MRD has prognostic value, but optimal application in clinical and research settings remains unclear, largely due to broad heterogeneity between trial designs, patient populations, therapeutic regimens, and disease subtypes. This latter variable is particularly relevant in lymphoma, as subtypes of disease present diverse biological characteristics that may impact the utility of MRD testing. At the Lymphoma Research Foundation’s inaugural 2023 MRD and Lymphoma Scientific Symposium, experts convened to discuss the state of MRD science and technology, current research findings and possible treatment implications, the emerging role of MRD in clinical trial design, regulatory considerations, pharmaceutical industry perspectives, current gaps, future directions, and next steps.

GROWING COMMUNITY THROUGH EVENTS

Lymphoma Research Foundation (LRF) provides opportunities for members of the lymphoma community and their friends to support innovative research and patient care by attending and sponsoring unique events across the country. Here are just a few examples of events that propelled LRF’s work in 2023.

Partners In Hope Chicago Raises More Than $110,000

On June 1, over 200 attendees gathered in Chicago for the inaugural Partners In Hope: A Scientific Social event, chaired by Kristi Hendriks, wife of lymphoma survivor and Chicago White Sox player Liam Hendriks. This evening honored longtime Lymphoma Research Foundation (LRF) Scientific Advisory Board member Dr. Leo I. Gordon, MD, of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University for his decades of commitment and care to his patients and his pioneering work that has changed the landscape of lymphoma research. Guests enjoyed a world-class wine tasting and raised more than $110,000 in support of critical lymphoma research on this special night.

Close Out Cancer

Throughout the 2023 Major League Baseball season, LRF was fortunate to team up the Chicago White Sox and Liam and Kristi Hendriks to create special “Close Out Cancer” T-shirts sold to supporting fans of the Sox and Hendriks in his lymphoma treatment. The proceeds of this one-of-a-kind campaign raised over $130,000 throughout the 2023 Sox season for LRF’s Patient Aid Grant program.

Golf Invitationals Raise More Than $350,000

LRF Annual Gala Raises More Than $1M

Hope means something different to everyone: a promising new treatment, a breakthrough in research, a lifeline during a difficult moment, and the promise of brighter days ahead. The LRF Annual Gala this year celebrated these Stories of Hope from across the lymphoma community at the Ziegfeld Ballroom in New York City on September 28. This year’s event honored Kara M. Kelly, MD, of Roswell Park Comprehensive Cancer Center with the Distinguished Leadership Award and Genmab with the Corporate Leadership Award in recognition of their commitment to serving the lymphoma community and advancing cures. This year’s event, which featured an exciting live auction, a rousing Raise it For LRF segment, and the inaugural Emerging Philanthropists After-Party, raised over $1.1M in support of LRF’s mission.

LRF supporters gathered on April 28 for the inaugural DC Metro Area Golf Outing, hosted at the Links at Challedon in Mount Airy, Maryland, one of the area’s premier golf courses. Former Washington football great Mark Rypien joined the golfers as they hit the links, raising over $50,000 in critical funds supporting LRF’s community of patients, survivors, researchers, and caregivers. The following month, LRF donors and supporters teed off at Quaker Ridge Golf Club in Scarsdale, New York, on May 23 for the 11th Annual LRF Golf Invitational. Golfers tested their skills on one of the most prestigious golf courses in the country and raised $300,000 to further LRF’s mission of eradicating lymphoma. The event, founded and chaired by Steve Prince and Jim Stern, has raised more than $3,000,000 since its inception.

GROWING COMMUNITY THROUGH FUNDRAISING

Thousands of people across the country turn their talents and interests into unique fundraising events to support the Lymphoma Research Foundation (LRF) mission. Whether they attended a Lymphoma Walk, participated in a marathon or road race, or created a new event, LRF’s partners, generous donors, and volunteers are all part of our growing community and helped to make 2023 one of the best years ever!

LA Marathon and NY Marathon

Team LRF took to the streets of Los Angeles alongside over 20,000 fellow racers for the 38th annual Los Angeles Marathon on March 19, 2023. The team of three dedicated runners raised $10,000 to power lymphoma research and to raise awareness for LRF’s mission as they ran 26.2 miles, starting at Dodger Stadium in downtown LA and crossing the finish line in Century City. Ten runners represented LRF at the NYC Marathon, raising $25,000 for lymphoma research and support services.

Fundraise Your Way Awards

On March 14, 2023, LRF staff and supporters joined together to celebrate its dedicated Fundraise Your Way volunteers during the inaugural Fundraise Your Way Awards. Volunteers across the country who turned their talents and interests into unique fundraising events were honored in categories including Rookie of the Year, Most Innovative Fundraiser, Ride Team of the Year, Walk Team of the Year, and Endurance Athlete of the Year.

LRF Inaugural Giving Day

Each year, September 15 marks World Lymphoma Awareness Day, with a number of buildings and landmarks across the globe lighting up red to spread lymphoma awareness worldwide. This year, September 15 held even more special significance as we marked it the inaugural LRF Giving Day: a celebration of all that we make possible together in our support of lymphoma patients and critical blood cancer research. Together, the lymphoma community raised over $32,000 on LRF Giving Day 2023 to power the next generation of lymphoma research and to give hope to patients in need.

Tony Corrado and The Chicago Lymphoma Walk

In July 2023, Corrado joined the Lymphoma Research Foundation at its Chicago Lymphoma Walk and raised more than $25,000 within just a few weeks. Over 100 people came to the event as part of Corrado’s team, traveling from as far as Indiana, Wisconsin, and New York.

Mattress Firm

LRF was proud to partner once again with our friends at Mattress Firm for a special campaign held October 18-31 that allowed customers the option to donate to the Foundation at the register. This campaign raised nearly $12,000 in just two weeks.

Relaunch of the Research Ride at the Comus Inn

Ninety riders took to the back roads of Montgomery County, Maryland, on Sunday, October 1, as they cycled to raise critical funds to power LRF’s research programs. The event kicked off at the foot of Sugarloaf Mountain and featured both 25- and 50-mile rides through beautiful landscapes offering panoramic views. Afterward, cyclists toasted their successes at an after-party held at the historic Comus Inn, celebrating the more than $105,000 they raised to fund the future of lymphoma research.

GROWING COMMUNITY THROUGH SUPPORT SERVICES

A diagnosis of lymphoma or chronic lymphocytic leukemia (CLL) can bring about many different emotions and numerous questions, whether you are newly diagnosed or seeking help with long-term survivorship. The Foundation offers a wide range of support services for people with lymphoma and their loved ones through the Lymphoma Research Foundation (LRF) Helpline. In 2023, trained Helpline staff provided individualized information on types of lymphoma, diagnostic tests, treatment options, potential side effects, and the latest in research to more than 10,000 patients and caregivers.

Contact the LRF Helpline toll-free at (800) 500-9976 or via email at helpline@lymphoma.org with any of your lymphoma-related questions, Monday–Friday, 9:30 a.m.–7:30 p.m. Eastern Standard Time (EST).

LRF Helpline

Throughout the past year and the entire pandemic, Helpline staff members provided a range of free services, including providing patients and caregivers with a list of questions to ask their healthcare team and conducting customized clinical trial searches through the LRF Clinical Trials Information Service. Through the Lymphoma Support Network, which has a membership of over 7,000, both patients and caregivers were connected with others who have gone through a similar experience. Patients and caregivers were also connected with financial assistance resources and other referrals for existing unmet medical and financial needs.

Focus on Lymphoma Mobile App

Mobile health technology is becoming an increasingly popular way to empower patients to take charge of their health by offering an easy way to track symptoms, record appointments, log lab results, and access educational resources. LRF has been leading the way in mobile health technology since the launch of its first-of-its-kind mobile app, Focus on Lymphoma, in 2013. The award-winning app was designed to help patients and caregivers better understand and manage their disease through comprehensive information tailored to the user’s specific lymphoma subtype. It provides tools to help users record/take notes during doctor sessions and track medications, blood results, and symptoms. Building upon the success of Focus on Lymphoma, LRF updated its app this year with several quality-of-life improvements based on user feedback to continue providing these important tools in the best possible way to lymphoma patients and their caregivers.

FINANCIALS FOR THE FISCAL YEAR ENDING JUNE 30, 2023

Contributions and grants

REVENUES

Special events and revenue

Investment income and other income

$14.8 million [85%]

$2.3 million [13%]

$0.4 million [2%]

PROGRAM SERVICES EXPENSES EXPENSES

Research

Education programs and patient services

Communications and advocacy

$7.0 million [63%]

$3.1 million [28%]

$1.1 million [9%]

Program services

Fundraising

Administration

$11.2 million [76%]

$2.1 million [14%]

$1.4 million [10%]

The Condensed Balance Sheets and Statements of Activities of the Lymphoma Research Foundation as of June 30, 2023, and 2022 have been derived from Lymphoma Research Foundation’s audited financial statements. The Lymphoma Research Foundation’s complete set of audited financial statements and related information can be found on the Lymphoma Research Foundation’s website, lymphoma.org. The Financial Statements have been audited by BDO.

GROWING COMMUNITY THROUGH OUR DONORS

The progress made by the Lymphoma Research Foundation in 2023 was made possible by its many supporters — patients, survivors, caregivers, family members, scientists, clinicians, nurses, communities, and companies — who recognize that partnership is critical to advancing innovative lymphoma research and the development of essential patient education programs.

LEADERSHIP DONORS

Thank you to our leadership donors for providing hope to the lymphoma community through their commitment to supporting innovative research and evidence-based educational resources.

2seventy bio

AbbVie Inc.

Acrotech Biopharma, LLC

Annette & Jeff Adams

Adaptive Biotechnologies

ADC Therapeutics

Walter J. Andrews

Aronow Foundation

AstraZeneca Pharmaceuticals, LP

The David R. & Patricia D.

Atkinson Foundation

Glenn R. August

John & Caroline Ballantine

Baranay Family Foundation

Michael & Lana Beaury

BeiGene USA, Inc.

Steven & Jennifer Benenson

Maxa Schutzbank Berid

Cathy S. Bernard

James Bisetti

Gary L. Blackwell

Jeffrey A. Block

The Boyd Charitable Donation Fund

Bristol-Myers Squibb

Robert & Arlette Britton

The Bruning Foundation

BTG International Inc.

Bruce & Christine Cheson

Chicago White Sox Charities

The Children’s Hospital of Buffalo Foundation

Estate of Christ H. Christensen

Coghill Family Foundation

Michael & Patty Cohen

Stacey Cohen

Morton & Joyce Coleman

Susan & James Colletti

Gladys Cook

Deborah Sue Coppola

CRISPR Therapeutics, Inc.

Joseph O. Cunningham, Jr.

Linda Cutter

Daiichi Sankyo, Inc.

Gary & Ellen Davis

Jane C. Davis

Laura De Reitzes

Lawrence D. & Gail Dobosh

Jean & Steven Eichberg

Eli Lilly & Company

Estate of Elvira Esterhazy

Robert & Amy Feilbogen

Norman J. & Doris Fisher Foundation

Richard I. Fisher

Foundation Medicine, Inc.

Gerald and Roberta Franklin

Charitable Foundation

Barbara & Jerry Freundlich

Frist Foundation

Michael & Lynn Froy

Bhargava & Harika Gannavarapu

Gantcher Family Foundation

Robert & Linda Gardner

Diane E. Geise

Genentech

Genmab US, Inc.

Gary & Lori Gertzog

Margie A. Gey

Tom & Jenn Goldstone

The Lillian & Larry Goodman Foundations

Andre Goy

Grassfield High School

Scott & Harriet Greenberg

Thomas & Mary Jo Habermann

Estate of Irving Hammer

Richard & Tracy Hazan

Edward D. Heffner

Kristi & Liam Hendriks

The Dubose & Dorothy Heward

Memorial Foundation

Helen Hidley

Gary & Diane Hirsch

Steven Hoffman

IFLI

Incyte Corporation

Ipsen Biopharmaceuticals, Inc.

Jazz Pharmaceuticals, Inc.

Johnson & Johnson Family Companies

Katherine Johnson

Stephanie Johnson

The Karches Foundation

Barrie & Glen Kassan

Richard & Suzanne Kayne

John Keating

James P. Kelly

Kara Kelly

Lawrence Kestin

Kite Pharma Inc.

William & Carolyn Klein

Jahanna & Thomas Knight

Leslie and Robert Kramig

Andrew & Elizabeth Kriegman

Andrew & Mara Kupferberg

Kyowa Kirin, Inc.

Sidney & Ruth Lapidus

Scot & Yumiko Larsen

Lehigh Chapter Of The Delta Chi Fraternity

Barry & Ilyse Leibowitz

Le-Vel Brands, LLC.

Michael & Carolyn Levine

Sandra Lundquist

Paul V. Majkowski, Esq.

Mallinckrodt Pharmaceuticals

Billi & Bernard Marcus

Carrie Marriott

Mel and Nora Masuda

Edward E. Matthews

Mattress Firm, Inc.

Robert & Laura McAuley

MEI Pharma, Inc.

Thomas G. Mendell

Eric & Debbi Mendelson

Bruce & Phipps Menk

Merck & Co., Inc.

David & Barbara Messer

Miltenyi Biomedicine

MorphoSys US Inc.

Eugene & Mary Murphy

John Nelson

The Jerome and Elaine Nerenberg Foundation

Liza Newman

The William and Anita Newman Foundation

Rose Novak

Novartis Pharmaceuticals Corp.

Nurix Therapeutics, Inc.

Morris W. Offit

Leigh & Cory Olson

ONO Pharma

Otto-Whalley Family Foundation

Diane & Tim Parks

Party for a Lifetime

Joseph E. Parzick

The Paul Foundation

Anne & Steve Pellegrini

Pfizer

David & Miriam Phalen & The Grinberg Family Foundation

Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC

Pisani Family Foundation

Andrew & Andrea Potash

The Prince Family Foundation

Matthew Prince

Steven & Debra Prince

Robert & Tracey Pruzan

Anthony Ragucci

Regeneron Pharmaceuticals, Inc.

Donna & Paul Reinbolt

Donna Riley

Steven & Stephanie Rosen

Lois & Jerry Rosenblum

Michele K. Ross

Roswell Park Comprehensive Cancer Center

Eric & Laurie Roth

Anne & David Rubin

Robert M. Rubin

Rutgers, The State University of New Jersey

Roy Ryan

Gregory E. Sacco, Jr.

Sanofi U.S.

Brad & Lesley Sarnoff

Mona Sarnoff

Norton & Elaine Sarnoff

Roberta Sarnoff

SBB Research Group Foundation

Daniel & Kiki Schneider

Seagen

Secura Bio

Lance Shackway

Kevin & Kimberly Shea

Paul & Joanne Simoneau

Michael & Carey Skinner

Starwood Property Trust

Jeffrey Stedman

The John & Louise Steegstra

Memorial Fund

Jane & James A. Stern

W. Clement and Jessie V. Stone Foundation

David Stump

Mayo & Elizabeth Stuntz

Madhvi & Ramesh Subrahmanian

Susan & Jeffrey Sussman

Jim & Mary Taglia

Joshua & Kimara Targoff

Lisa A. Taverna

Laura Tepper

Ira & Nan Theodore

Diane & Gaylord Thormodsgard

Shawn & Richard Tomasello

Thomas N. Tryforos

Ann Tunney

Phil Variano

Byron & Laurie Vielehr

Anthony Volpe

Michael & Laura Werner

Richard L. & Lois S. Werner

Family Foundation

Robert Werner

Bruce W. Wetzel

Judy Whalley

Donald & Virginia Whinfrey

Sharon Wickes

Michael & Rebecca Williams

Suzanne Williams

Elizabeth Winslow

Penny D. Wolf

Yablans Family Foundation

Andrea & Bruce Yablon

The Richard H. Yearick Foundation

Adelaide W. Zabriskie Fund

Kurt & Denise Zumwalt

CIRCLE OF HOPE

Thank you to our Circle of Hope partners, whose monthly support ensures we can respond to the needs of our community and invest in further groundbreaking research year-round.

Ileen Akers

Jason Albano

Keith Alsberg

Gary S. Anthony

Angela M. Baglione

Kathryn Baine

Micah Banner

Kaethe Bierbach

Tony Blanco

Christine M. Bolanis

Dana Bork

Barbara G. Bornstein

Mary Brady

Arlene R. Bruskin

Teri Burke

Steven Chudnick

Erwin & Patricia Cohen

Mary R. Coleman

Frances Collazo

Michelle & Andrew Dahl

Toby R. Davidow

Peter De Lijser

Kevin Degroft

Michael DeJoy

Megan Denecour

Victoria Dillon

Carolyn Dobson

Shannon Dorsey

Kenneth P. Ducote

Susana Enriquez

Douglas Fairbanks

Frank C. Famiano

Richard & Lynne Feinstein

Dennis & Debbie Ferguson

Theresa Fillinger

Yury Flom

Thomas J. Forbes

Juliana Fuller

Patricia Gandy

Cynthia Gargagliano

Margaret A. Ghering

John Greabe & Martha Madsen

Andrew Greenwood

Kyle Haines

Jeanne & Gerry Hall

Sue Hammond

Elizabeth Haughie

Joshuah Hernandez

Maria Hernandez

Judy Herriman

Judith & Francis J. Higgins

Rick Hind

Rosalie Hish

Kian Javadi Namin

Ajay Kalra

Susan Kelley

Mary K King

Lawrence Kirzhner

Michael Klaessy & Susan

Poll Klaessy

Aaron Krause

Brian Kutschke

Label LLC

Desiree Lamonico

Richard & Michelle Lebreux

Erica Lecce

Brandon Lespron

Elizabeth Lesser

Casey Lipscomb

Natasha Llewellyn

Larry Loose

Ira & Lois Lunsk

Celia Maldonado

Blase Masini

Joellen McGugan

Ashley Mignosi

Barbara A. Miller

Johanna Miller

Paul M. Mills

Shaw Miseyko

Teresa Myers

Sharyn A. Novotny

John O’Rourke

Jamie Pawelek

Daniel Peacock

Thomas Peele

Don Pendergrass

Linda P. Pepe

Benjamin & Elizabeth A. Pickett

Rebecca A. Pimentel

THE MASON SOCIETY

Joel Pollick & Emily Franklin

Erin Poole & David Gooch

William M. Popper

Arthur & Deborah Price

Angela Reel

James E. Rodgers

Lauren Roland

Kevin Rosier

Rebecca Russell

Mark Salandra

Lawrence Simon

Roger W. Smith &

Sheila Stamper

Jeffrey Souter

Donna St. George

Rod Stoner

Danielle Surra

Vincent S. Talerico

Isaac Thomas

Alicia Turner

Daniel & Laura Wallenstein

Bruce & Sandra Wells

Martin White & Nancy J. Trapp

Christopher H. Wilder

Jennifer Wise

Annelle Woggon

Richard Zavadowski

Maggie Zeqiri

Alan Zube

The Mason Society honors those who support the Lymphoma Research Foundation’s work through bequests or other planned gifts. Planned giving provides an important and long-term funding source that can be used to accelerate biomedical research and the development of new treatments now and in the future.

Susan E. Baer

Amy Louise Barnett

Maxa Schutzbank Berid

Carl & Debbie Berkowitz

John Cohee

Carol Davey

Jean & Steven Eichberg

Michael Fisher

Gregory Gest

Tom S. Lakritz

Judith Lender

Debra & Michael Linick

Kimberly A. Metcalf

Lawrence Prager &

Linda Myszak

Harris M. Sholman

Robert Werner

IN LOVING MEMORY JERRY FREUNDLICH

In 2023, the Lymphoma Research Foundation (LRF) lost its co-founder and champion, Jerry Freundlich.

As a result of Jerry’s personal journey with non-Hodgkin lymphoma, he and his wife Barbara founded the Foundation, recognizing the significant need to increase investment in lymphoma research and support those personally impacted by a lymphoma diagnosis. Working with the late Dr. Joseph Bertino, the Foundation was created in the Freundlichs’ home and eventually became the largest lymphomaspecific organization in the country, led by an elite Scientific Advisory Board comprised of the world’s leading lymphoma researchers and clinicians. In addition to being its co-founder, Jerry served the organization as President and Chair of the Board, Director, and most recently as a Director Emeritus.

Jerry is remembered as a lymphoma survivor whose generosity and vision have impacted the lives of millions of members of the lymphoma community. The Foundation will continue this life-saving work, always remembering Jerry’s goal to see a world without lymphoma.

To that end, in 2023, LRF established a new scientific initiative aimed at better understanding existing survivorship care recommendations for patients with hematologic malignancies. This initiative, led by LRF’s Scientific Advisory Board, will include a national workshop series to address these issues and inform the Foundation’s patient support services and education programs.

The highlight of each workshop will be an invited lecture intended to address the most pivotal survivorship issues in the field. The lecturers will be lymphoma and cancer survivorship experts and advocates who share LRF’s mission to eradicate lymphoma and serve all those touched by this disease. The Foundation has named this distinguished lecture series “The Founder’s Lecture” in memory of Jerry Freundlich. LRF could think of no better way to honor Jerry’s legacy than by naming this prestigious and important keynote lecture series in his memory.

When

Thank you for ensuring LRF can serve those touched by this disease well into the future and ultimately eradicate lymphoma.

To learn more, contact Lynne Winter at (646) 531-5184 or lwinter@lymphoma.org, or visit lymphoma.org/legacy